Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease
Ànna Pavlova, Diane L. Lynch, Isabella Daidone, et al.
Chemical Science (2020) Vol. 12, Iss. 4, pp. 1513-1527
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding
H. T. Henry Chan, Marc A. Moesser, Rebecca K. Walters, et al.
Chemical Science (2021) Vol. 12, Iss. 41, pp. 13686-13703
Open Access | Times Cited: 73
A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design
Carlos A. Ramos‐Guzmán, J. Javier Ruiz‐Pernía, Iñaki Tuñón
Chemical Science (2021) Vol. 12, Iss. 10, pp. 3489-3496
Open Access | Times Cited: 59
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
Juliana C. Ferreira, Samar Fadl, Wael M. Rabeh
Journal of Biological Chemistry (2022) Vol. 298, Iss. 6, pp. 102023-102023
Open Access | Times Cited: 44
Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
Yuma Handa, Koji Okuwaki, Yusuke Kawashima, et al.
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 10, pp. 2249-2265
Open Access | Times Cited: 11
Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease
Ashim Nandi, Mojgan Asadi, Aoxuan Zhang, et al.
ACS Catalysis (2025), pp. 1158-1169
Closed Access | Times Cited: 1
Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography
Daniel W. Kneller, G.N. Phillips, Kevin L. Weiss, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4991-5000
Open Access | Times Cited: 46
Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
Hani A. Alhadrami, Ahmed M. Sayed, Ahmed M. Sharif, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2654-2654
Open Access | Times Cited: 46
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study
Manuel A. Llanos, Melisa E. Gantner, Santiago Rodrı́guez, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 8, pp. 3758-3770
Open Access | Times Cited: 42
Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
Marina Macchiagodena, Marco Pagliai, Piero Procacci
Journal of Molecular Graphics and Modelling (2021) Vol. 110, pp. 108042-108042
Open Access | Times Cited: 42
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
Daniel W. Kneller, Hui Li, Stephanie Galanie, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 17366-17383
Open Access | Times Cited: 39
Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations
Shanshan Liang, Xinguo Liu, Shaolong Zhang, et al.
Physical Chemistry Chemical Physics (2021) Vol. 24, Iss. 3, pp. 1743-1759
Closed Access | Times Cited: 37
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
Jens Gläser, Ada Sedova, Stephanie Galanie, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 4, pp. 255-265
Open Access | Times Cited: 24
Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease
Joseph Clayton, Vinícius M. de Oliveira, Mohamed Fouad Ibrahim, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 11, pp. 3521-3533
Open Access | Times Cited: 15
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
David Chmielewski, Eric Wilson, Grigore Pintilie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Impact of Warhead Modulations on the Covalent Inhibition of SARS-CoV-2 Mpro Explored by QM/MM Simulations
Sérgio Martí, Kemel Arafet, Alessio Lodola, et al.
ACS Catalysis (2021) Vol. 12, Iss. 1, pp. 698-708
Open Access | Times Cited: 28
Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design
Laura Zanetti‐Polzi, Micholas Dean Smith, Chris Chipot, et al.
The Journal of Physical Chemistry Letters (2021) Vol. 12, Iss. 17, pp. 4195-4202
Open Access | Times Cited: 26
SARS-COV-2 Mpro conformational changes induced by covalently bound ligands
Gláucio Monteiro Ferreira, Thales Kronenberger, Arun Kumar Tonduru, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12347-12357
Open Access | Times Cited: 24
Fullerenes against COVID-19: Repurposing C60 and C70 to Clog the Active Site of SARS-CoV-2 Protease
Tainah Dorina Marforio, Edoardo Jun Mattioli, Francesco Zerbetto, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1916-1916
Open Access | Times Cited: 16
pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity
Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, et al.
Journal of Biological Chemistry (2022) Vol. 299, Iss. 2, pp. 102790-102790
Open Access | Times Cited: 16
Comparative Performance of High-Throughput Methods for Protein pKa Predictions
Wanlei Wei, Hervé Hogues, Traian Sulea
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5169-5181
Open Access | Times Cited: 10
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
Norman Tran, Sathish Dasari, Sarah Barwell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 9
Crystal structure of SARS-CoV 3C-like protease with baicalein
Jingwen Feng, Dongyang Li, Jin Zhang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 611, pp. 190-194
Open Access | Times Cited: 14
Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
Ahmed M. Sayed, Alyaa Hatem Ibrahim, Nasir Tajuddeen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115226-115226
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top